Trial Outcomes & Findings for Community Support Program for Lung Cancer Screening (NCT NCT06207435)

NCT ID: NCT06207435

Last Updated: 2025-09-02

Results Overview

The Primary Outcome measures the rate of appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

242 participants

Primary outcome timeframe

12 months

Results posted on

2025-09-02

Participant Flow

Participant milestones

Participant milestones
Measure
West Philadelphia CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
West Philadelphia Non CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
Southwest Philadelphia Residents
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
Overall Study
STARTED
26
165
51
Overall Study
COMPLETED
26
165
51
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Community Support Program for Lung Cancer Screening

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
West Philadelphia CSP Participants
n=26 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
West Philadelphia Non CSP Participants
n=165 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
Southwest Philadelphia Residents
n=51 Participants
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
Total
n=242 Participants
Total of all reporting groups
Age, Customized
Age 18-89
26 participants
n=5 Participants
165 participants
n=7 Participants
51 participants
n=5 Participants
242 participants
n=4 Participants
Sex: Female, Male
Female
18 Participants
n=5 Participants
98 Participants
n=7 Participants
28 Participants
n=5 Participants
144 Participants
n=4 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
67 Participants
n=7 Participants
23 Participants
n=5 Participants
98 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
26 Participants
n=5 Participants
162 Participants
n=7 Participants
51 Participants
n=5 Participants
239 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
2 Participants
n=7 Participants
0 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
2 Participants
n=7 Participants
0 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
26 Participants
n=5 Participants
149 Participants
n=7 Participants
48 Participants
n=5 Participants
223 Participants
n=4 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
11 Participants
n=7 Participants
3 Participants
n=5 Participants
14 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Region of Enrollment
United States
26 participants
n=5 Participants
165 participants
n=7 Participants
51 participants
n=5 Participants
242 participants
n=4 Participants
Scheduled Lung Cancer Screening
26 participants
n=5 Participants
165 participants
n=7 Participants
51 participants
n=5 Participants
242 participants
n=4 Participants

PRIMARY outcome

Timeframe: 12 months

The Primary Outcome measures the rate of appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).

Outcome measures

Outcome measures
Measure
West Philadelphia CSP Participants
n=26 Participants
West Philadelphia CSP Participants For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
West Philadelphia Non CSP Participants
n=165 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
Southwest Philadelphia Residents
n=51 Participants
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
Percentage of Scheduled Lung Cancer Screening Appointments Attended by Participants
88 % of lcs appointment attendance
68 % of lcs appointment attendance
64 % of lcs appointment attendance

SECONDARY outcome

Timeframe: 12 months

The Secondary outcome is a measurement of the percentage of eligible participants (West Philadelphia residents) who chose to opt into the CSP (as opposed to eligible participants who did not).

Outcome measures

Outcome measures
Measure
West Philadelphia CSP Participants
n=191 Participants
West Philadelphia CSP Participants For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
West Philadelphia Non CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
Southwest Philadelphia Residents
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
Percentage of CSP Enrollment
14 percentage of participants

Adverse Events

West Philadelphia Residents

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Non West Philadelphia Residents

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Farouk Dako

University of Pennsylvania

Phone: 2673091241

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place